1. Home
  2. APOG vs PSNL Comparison

APOG vs PSNL Comparison

Compare APOG & PSNL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

APOG

Apogee Enterprises Inc.

HOLD

Current Price

$35.67

Market Cap

697.8M

ML Signal

HOLD

Logo Personalis Inc.

PSNL

Personalis Inc.

HOLD

Current Price

$5.78

Market Cap

729.1M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
APOG
PSNL
Founded
1949
2011
Country
United States
United States
Employees
N/A
N/A
Industry
Auto Parts:O.E.M.
Medical Specialities
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
697.8M
729.1M
IPO Year
1994
2019

Fundamental Metrics

Financial Performance
Metric
APOG
PSNL
Price
$35.67
$5.78
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
1
5
Target Price
$47.00
$12.20
AVG Volume (30 Days)
201.0K
1.5M
Earning Date
04-24-2026
05-05-2026
Dividend Yield
3.04%
N/A
EPS Growth
N/A
33.58
EPS
1.74
N/A
Revenue
$1,360,994,000.00
$69,648,000.00
Revenue This Year
$4.12
$15.34
Revenue Next Year
N/A
$41.46
P/E Ratio
$20.39
N/A
Revenue Growth
N/A
N/A
52 Week Low
$30.75
$3.63
52 Week High
$46.14
$11.50

Technical Indicators

Market Signals
Indicator
APOG
PSNL
Relative Strength Index (RSI) 53.28 34.51
Support Level $33.27 $4.65
Resistance Level $35.88 $9.56
Average True Range (ATR) 1.08 0.43
MACD 0.22 0.02
Stochastic Oscillator 63.29 6.43

Price Performance

Historical Comparison
APOG
PSNL

About APOG Apogee Enterprises Inc.

Apogee Enterprises Inc is a provider of architectural products and services for enclosing buildings, and high-performance glass and acrylic products used in applications for preservation, protection, and enhanced viewing. The company's operating segment consists of the Architectural Metals Segment, Architectural Services Segment, Architectural Glass Segment, and Performance Surfaces Segment. The company generates the majority of its revenue from the Architectural Metals Segment, which designs, engineers, fabricates, and finishes aluminum window, curtainwall, storefront, and entrance systems used principally in non-residential construction. The company generates revenue geographically from the United States, Canada, and Brazil, with the majority coming from the United States.

About PSNL Personalis Inc.

Personalis Inc is a provider of genomic sequencing and analytics solutions to support the development of personalized cancer vaccines and other next-generation cancer immunotherapies. It has one segment, the sale of sequencing and data analysis services. Its products include ImmunoID NeXT, NeXT Personal, NeXT Dx Test, and other pharma research solutions.

Share on Social Networks: